TS
IDXX icon

Triglav Skladi’s Idexx Laboratories IDXX Stock Holding History

Triglav Skladi’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-985
Closed -$666K – 180
2025
Q4 		$666K Sell
985
-415
-30% -$283K 0.04% 143
2025
Q3 		$894K Hold
1,400
– – 0.06% 117
2025
Q2 		$751K Buy
1,400
+725
+107% +$347K 0.05% 118
2025
Q1 		$283K Hold
675
– – 0.02% 128
2024
Q4 		$279K Buy
+675
New +$296K 0.02% 122

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Triglav Skladi's IDXX Position: Q1 2026 in Review

Triglav Skladi sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 985 shares — an estimated $666K sold.

Triglav Skladi first reported a position in IDXX in Q4 2024 and held it in 5 quarters. The position peaked at $894K in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Triglav Skladi reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Triglav Skladi sold 985 Idexx Laboratories shares in Q1 2026, an estimated $666K.
  • Triglav Skladi first reported a position in Idexx Laboratories in Q4 2024 and held it in 5 quarters.
  • Triglav Skladi's Idexx Laboratories position peaked at $894K in Q3 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.